focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Oil and shares slide as sanctions, virus fears strike

Tue, 23rd Mar 2021 12:56

(Recasts)

* U.S., Europe sanctions against China hit shares

* Powell to testify from 1600 GMT on U.S. recovery

* Oil slides 4% amid demand fears

* Global currencies vs. dollar https://tmsnrt.rs/2PmYOcE

By Lawrence White and Alun John

LONDON/HONG KONG, March 23 (Reuters) - Oil prices slumped
and shares slipped from a one-year peak on Tuesday as a wave of
coronavirus infections, a fresh lockdown in Germany, and U.S.
and European sanctions over China combined to curb risk appetite
worldwide.

Brent crude futures dropped by $2.59, or 4%, to
$62.03 a barrel by 1225 GMT and U.S. West Texas Intermediate
(WTI) crude futures likewise slid 4% on concerns that new
pandemic curbs and slow vaccine rollouts in Europe will hold
back a recovery in demand.

Energy stocks were also hit, with Chevron Corp,
Occidental Petroleum Corp and Exxon Mobil Corp
shedding between 1.5% and 3.5% pre-market, while travel-related
stocks also fell as much as 4%.

The STOXX index of 600 European shares slipped
0.4%, while the benchmark 10-year German government bond yield
dropped 4 basis points to -0.351%, its lowest in a
week, and gold inched up as investors sought safer assets.

U.S. stock index futures slid ahead of Congressional
testimony by Federal Reserve Chair Jerome Powell and Treasury
Secretary Janet Yellen later in the day that may shed light on
the pace of economic rebound from the COVID-19 pandemic.

In remarks prepared for delivery to the hearing on Tuesday
morning, Powell said the U.S. economic recovery had progressed
"more quickly than generally expected".

The congressional hearings begin at 12 p.m. ET (1600 GMT).

"The FOMC last week laid out pretty clearly what the Fed's
view is with regard to rates ... the next thing that markets
will focus on is maybe getting some details from Yellen with
regard to further infrastructure investment," said Alex Wolf,
head of investment strategy for Asia at J.P. Morgan Private
Bank, referring to a statement from the Federal Open Market
Committee.

MIXED MOOD

A mixed bag of new Western sanctions on China, coronavirus
concerns and Turkish tumult after President Tayyip Erdogan's
shock sacking of the central bank chief at the weekend left
investors awaiting a firmer signal.

The Turkish lira appeared to find a floor after
Monday's historic 7.5% slump, rising as much as 1% in volatile
trading to 7.8742 against the dollar by 1234 GMT.

In Asia, MSCI's broadest index of Asia-Pacific shares
outside Japan dropped 0.66%, hurt by a 0.95%
fall in Chinese blue chips as a fresh wave of U.S. and
European sanctions over human rights abuses in Xinjiang hit.

The sanctions on China prompted an immediate riposte from
Beijing against the EU that appeared broader, including European
lawmakers, diplomats, institutes and families.

Adding to market jitters were further worries over the
efficacy of the AstraZeneca Plc vaccine developed with
Oxford University after a U.S. health agency said the drugmaker
may have included outdated information in its data.

SUMMER CANCELLED?

The fall in oil prices, travel and energy-related stocks was
spearheaded by news Germany had extended its lockdown until
April 18, reversing plans for a gradual reopening of the economy
agreed earlier this month.

"Global travel is still looking like it could be a while
away," said Matt Stanley, a fuel broker at Star Fuels in Dubai,
adding that a second-half recovery in oil demand looked doubtful
as lockdowns remain the order of the day.

Benchmark 10-year U.S. Treasury notes last
yielded 1.6523%, down from 1.732% late on Friday.

The dollar gained slightly against a basket of six major
currencies, last trading at 92.1, having slipped 0.32% on
Monday, while making advances against the kiwi, Aussie and
sterling.

Spot gold rose slightly to $1,740 per ounce by 1239
GMT, buoyed by easing U.S. Treasury yields.

The New Zealand dollar hit a three-month low after
the government introduced taxes to curb housing speculation, a
move investors reckoned could allow the central bank to hold low
interest rates for longer with less risk of a property bubble.

(Reporting by Alun John in Hong Kong, Chris Prentice in
Washington, Lawrence White in London; Additional reporting by
Luoyan Liu in Shanghai; Editing by Catherine Evans)

More News
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.